ANIL PAREKH: Open Payments
NPI 1154343440 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,991 in 71 payments from 13 companies in 2025. Trend: 2023 $2,478 · 2024 $2,036 · 2025 $1,991
Food & beverage: $1,991
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $691 |
| Neurocrine BioSciences, Inc. | 7 | $227 |
| Teva Pharmaceuticals USA, Inc. | 15 | $215 |
| Axsome Therapeutics, Inc. | 5 | $183 |
| Alkermes, Inc. | 6 | $153 |
| Janssen Pharmaceuticals, Inc | 5 | $142 |
| Collegium Pharmaceutical, Inc. | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 5 | $79 |
| Vanda Pharmaceuticals Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
Products named: CAPLYTA, INGREZZA, Auvelity, INVEGA SUSTENNA, UZEDY, Jornay PM, AUSTEDO XR, ARISTADA.
Industry payments across PA — which companies pay providers there.
